However, the initial choice of long-acting inhaled bronchodilator is not specified ... in preventing COPD exacerbations. In this randomized, controlled, multicenter, international trial, 7376 ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.

Bronchodilator therapy forms the mainstay of treatment for people with COPD. Bronchodilators work ... of life and reduce the risk of experiencing exacerbations. It is also important to match ...

Traditionally, COPD management has relied on bronchodilators ... The other big area of interest is reducing COPD exacerbation frequency. For this, we're studying targeted lung denervation ...

The use of antibiotics in combination with oral corticosteroids to treat patients with mild-to-moderate exacerbations ... guidelines about bronchodilator use in patients with COPD and CVD are ...

Current treatment options for COPD include bronchodilators such as beta2 ... Treatment with Dupixent was shown to reduce COPD exacerbations by 30% in the BOREAS trial and by 34% in the NOTUS ...

The right treatment plan can help you control your COPD symptoms and avoid exacerbations (flareups). These include shortness ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The drug was administered twice-daily using a nebuliser as a chronic maintenance therapy for people with COPD in the ENHANCE-2 study, cutting the rate of moderate to severe exacerbations ...

Furthermore, an analysis of ensifentrine’s impact on reducing exacerbation rates and COPD-related healthcare resource utilization over 48 weeks will also be presented. “Ensifentrine is a ...